PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
This Quarter Return
+8.09%
1 Year Return
+49.21%
3 Year Return
+140.34%
5 Year Return
+258.27%
10 Year Return
–
AUM
$104M
AUM Growth
+$104M
(+18%)
Cap. Flow
+$5.08M
Cap. Flow
% of AUM
4.87%
Top 10 Holdings %
Top 10 Hldgs %
28.3%
Holding
118
New
25
Increased
26
Reduced
38
Closed
11
Top Buys
| 1 |
UBX
Unity Biotechnology
UBX
|
$4.08M |
| 2 |
Spotify
SPOT
|
$1.54M |
| 3 |
Centene
CNC
|
$1.29M |
| 4 |
Madison Square Garden
MSGS
|
$1.29M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$1.22M |
Top Sells
| 1 |
ALNA
Allena Pharmaceuticals, Inc. Common Stock
ALNA
|
$3.61M |
| 2 |
Bristol-Myers Squibb
BMY
|
$3.52M |
| 3 |
Microsoft
MSFT
|
$2.51M |
| 4 |
Baxter International
BAX
|
$1.89M |
| 5 |
Molina Healthcare
MOH
|
$1.32M |
Sector Composition
| 1 | Healthcare | 52.96% |
| 2 | Technology | 15.11% |
| 3 | Communication Services | 11.71% |
| 4 | Consumer Discretionary | 4.16% |
| 5 | Financials | 3.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNCE
101
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – |
-14,916
| Closed | -$333K |
|
|
LCI
102
DELISTED
Lannett Company, Inc.
LCI
| – | – |
0
| – | – |
|
|
GBT
103
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
-946
| Closed | -$46K |
|
|
MNK
104
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
0
| – | – |
|
|
105
Bristol-Myers Squibb
BMY
$96B
| – | – |
-55,719
| Closed | -$3.52M |
|
106
DexCom
DXCM
$29.5B
| – | – |
-7,932
| Closed | -$588K |
|
107
iShares MSCI Emerging Markets ETF
EEM
$19B
| – | – |
0
| – | – |
|
108
Heron Therapeutics
HRTX
$207M
| – | – |
0
| – | – |
|